Michael Willmann

7PUBLICATIONS
31CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik

|Sep 14, 2020
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells.

Susanne Gamperl, Gabriele Stefanzl, Michael Willmann

|Jul 10, 2019
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

Susanne Gamperl, Gabriele Stefanzl, Barbara Peter

|Aug 24, 2018
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms.

Michael Willmann, Emir Hadzijusufovic, Olivier Hermine

|Aug 11, 2016
IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

K Bauer, E Hadzijusufovic, S Cerny-Reiterer

Pageof 2